Ondine Biomedical (LON:OBI) Trading Up 0.3% – Here’s What Happened

Ondine Biomedical Inc. (LON:OBI)’s stock price shot up 0.3% on Friday . The stock traded as high as C$9.28 and last traded at C$9.28. 5,323 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 279,142 shares. The stock had previously closed at C$9.25.

Ondine Biomedical Trading Up 0.3 %

The company has a debt-to-equity ratio of 25.95, a quick ratio of 8.26 and a current ratio of 1.36. The firm has a market capitalization of C$66.72 million, a PE ratio of -2.80 and a beta of 0.10. The stock’s 50-day simple moving average is C$10.02 and its 200-day simple moving average is C$9.37.

Insider Activity

In other news, insider Carolyn Cross bought 200,775 shares of the stock in a transaction dated Thursday, January 30th. The stock was bought at an average price of C$12.00 per share, for a total transaction of C$2,409,300.00. Insiders own 36.69% of the company’s stock.

About Ondine Biomedical

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.